A New Approach to Treating Alzheimer's and Parkinson's is by reviving the Brain's Waste-Clearing System

Donanemab is the second Alzheimer drug the FDA has granted approval.

Key Takeaways Blood tests that accurately and reliably detect Alzheimer’s hallmark brain changes signal a shift to simpler, more accurate...

In the realm of medical science, advancements are continually being made to improve our understanding and management of complex diseases....

JAMA report on how blood biomarker changes of Alzheimer's impact development of All-Cause Dementia

Changes in Alzheimer's Disease blood biomarkers impact the development of All-Cause dementi

New JAMA Audio Update on latest Alzheimer Disease Medical News

9/27/23 Aducanumab. Crezenumab. Donanemab. Gantenerumab. Lecanemab. Solanezumab. Those multisyllable drug names may not trip off the...

1/24/24 [Aducanumab and Alzheimer's] Applying magnetic resonance imaging–guided focused ultrasound to the brain temporarily opens the...

BACKGROUND Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but...

Today, an estimated 6.7 million people over 65 years of age in the United States are living with dementia, and they are cared for, in...

A diet that prioritizes plant-based foods such as leafy greens, nuts, fish, and olive oil—known as the Mediterranean-Dietary Approaches...

JAMA. Published online July 17, 2023. doi:10.1001/jama.2023.11701 A two year review of Alzheimer's clinical trials of antibodies like...

Alzheimer’s Solanezumab testing forms of amyloid at different stages had mixed results. Solanezumab, which targets monomeric amyloid in...

JAMA, Published 7/17/23 This article updated July 17, 2023; was first published May 3, 2023 (excerpts) Question Does Donanemab, a...

Study of green tea and other molecules uncovers new therapeutic strategy for Alzheimer’s NIH National Institute on Aging February 16,...

Alzheimer’s may increase DNA variants in brain neurons NIH National Institute on Aging March 23, 2023 Neurons in the brains of people...

Hydroxychloroquine lowers dementia risk in humans, improves molecular signs of Alzheimer’s in mouse and cell models           NIH...

Sense of smell linked to speed of brain loss and cognitive decline NIH National Institute on Aging March 30, 2023 Reprint Having a good...

Blood test method may predict Alzheimer’s protein deposits in the brain NIH NEWS RELEASE March 2020 Older Update with Value NIH-funded...